Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens

Ravi Ramakrishna, W. K. Aldous, S. P. Murray, D. P. Tracy, W. E. Caras, T. A. Dillard

Research output: Contribution to journalArticle

Abstract

Purpose: The ribonucleoprotein enzyme telomerase occurs in immortal lines of mammalian cells including germ cells and most malignancies. The activity of telomerase has potential to emerge as a clinical tumor marker in prognosis or therapeutic options for lung cancer. Telomerase activity has been described in surgical and autopsy specimens of carcinomas but seldom in diagnositc specimens. We prospectively evaluated the feasibility of assessing telomerase activity in diagnostic specimens of thoracic neoplasms. Methods: We assessed telomerase activity in twenty-five bronchoscopic, thoracentesis and fine needle specimens by gel electrophoresis and a PCR ELISA assay using a single blinded study design. The clinical specimens had cytologically confirmed malignancy consisting of 9 small cell carcinomas and 16 non-small cell lung carcinomas including 2 carcinomas metastatic to the thorax. In addition, we noted an absence of significant telomerase activity by the gel electrophoresis technique in four patients with pneumonia, trapped lung or eosinophilic pleuritis. Results: We found telomerase activity by gel electrophoresis in 17 of 25 specimens (68%) including 10 of 13 broncoscopy specimens (77 %), 3 of 8 thoracentesis specimens (38 %) and 4 of 4 fine needle aspirates (100%). When we examined the results by tissue type of carcinoma we found that 6 of 9 small cell carcinomas (68%), and 11 of 16 non-small cell specimens (69%) had gel activity. Six specimens (24%) had relatively high telomerase activities (>0.312 A 450-690) by PCR ELISA assay. These consisted of 2 of 9 small cell (22%) and 4 of 16 non-small cell specimens (25%). Brushings, transbronchial needle aspirates and fine needle aspirates appeared to have greater combined sensitivity (92%) than pleural fluid and lavage specimens (42%). Conclusions: Detection of telomerase activity in thoracic malignancies appears feasible from clinical diagnostic specimens such as bronchoscopy, thoracentesis and fine needle aspirates. The prevalence of telomerase activity by gel electrophoresis was similar in the small cell and non-small cell specimens in this study. Telomerase activity has moderate sensitivity as an indicator of cytologically confirmed malignancy. Clinical Implications: Telomerase activity can be detected in clinical diagnostic specimens from patients with cytologically confirmed lung cancer. Should telomerase prove to be a valuable tumor marker, positivity in diagnostic specimens may obvitate the need for more invasive procedures. Future studies using diagnostic specimens may aid in assessing the value of telomerase activity as a tumor marker.

Original languageEnglish (US)
Pages (from-to)305S
JournalCHEST
Volume114
Issue number4 SUPPL.
StatePublished - Oct 1 1998

Fingerprint

Telomerase
Bronchoscopy
Needles
Gels
Electrophoresis
Tumor Biomarkers
Small Cell Carcinoma
Thoracentesis
Carcinoma
Thoracic Neoplasms
Lung Neoplasms
Neoplasms
Thorax
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction
Pleurisy
Ribonucleoproteins
Therapeutic Irrigation
Germ Cells
Non-Small Cell Lung Carcinoma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Ramakrishna, R., Aldous, W. K., Murray, S. P., Tracy, D. P., Caras, W. E., & Dillard, T. A. (1998). Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens. CHEST, 114(4 SUPPL.), 305S.

Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens. / Ramakrishna, Ravi; Aldous, W. K.; Murray, S. P.; Tracy, D. P.; Caras, W. E.; Dillard, T. A.

In: CHEST, Vol. 114, No. 4 SUPPL., 01.10.1998, p. 305S.

Research output: Contribution to journalArticle

Ramakrishna, R, Aldous, WK, Murray, SP, Tracy, DP, Caras, WE & Dillard, TA 1998, 'Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens', CHEST, vol. 114, no. 4 SUPPL., pp. 305S.
Ramakrishna R, Aldous WK, Murray SP, Tracy DP, Caras WE, Dillard TA. Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens. CHEST. 1998 Oct 1;114(4 SUPPL.):305S.
Ramakrishna, Ravi ; Aldous, W. K. ; Murray, S. P. ; Tracy, D. P. ; Caras, W. E. ; Dillard, T. A. / Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens. In: CHEST. 1998 ; Vol. 114, No. 4 SUPPL. pp. 305S.
@article{70c65cf3818144b0a4f8eecb2e2e0653,
title = "Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens",
abstract = "Purpose: The ribonucleoprotein enzyme telomerase occurs in immortal lines of mammalian cells including germ cells and most malignancies. The activity of telomerase has potential to emerge as a clinical tumor marker in prognosis or therapeutic options for lung cancer. Telomerase activity has been described in surgical and autopsy specimens of carcinomas but seldom in diagnositc specimens. We prospectively evaluated the feasibility of assessing telomerase activity in diagnostic specimens of thoracic neoplasms. Methods: We assessed telomerase activity in twenty-five bronchoscopic, thoracentesis and fine needle specimens by gel electrophoresis and a PCR ELISA assay using a single blinded study design. The clinical specimens had cytologically confirmed malignancy consisting of 9 small cell carcinomas and 16 non-small cell lung carcinomas including 2 carcinomas metastatic to the thorax. In addition, we noted an absence of significant telomerase activity by the gel electrophoresis technique in four patients with pneumonia, trapped lung or eosinophilic pleuritis. Results: We found telomerase activity by gel electrophoresis in 17 of 25 specimens (68{\%}) including 10 of 13 broncoscopy specimens (77 {\%}), 3 of 8 thoracentesis specimens (38 {\%}) and 4 of 4 fine needle aspirates (100{\%}). When we examined the results by tissue type of carcinoma we found that 6 of 9 small cell carcinomas (68{\%}), and 11 of 16 non-small cell specimens (69{\%}) had gel activity. Six specimens (24{\%}) had relatively high telomerase activities (>0.312 A 450-690) by PCR ELISA assay. These consisted of 2 of 9 small cell (22{\%}) and 4 of 16 non-small cell specimens (25{\%}). Brushings, transbronchial needle aspirates and fine needle aspirates appeared to have greater combined sensitivity (92{\%}) than pleural fluid and lavage specimens (42{\%}). Conclusions: Detection of telomerase activity in thoracic malignancies appears feasible from clinical diagnostic specimens such as bronchoscopy, thoracentesis and fine needle aspirates. The prevalence of telomerase activity by gel electrophoresis was similar in the small cell and non-small cell specimens in this study. Telomerase activity has moderate sensitivity as an indicator of cytologically confirmed malignancy. Clinical Implications: Telomerase activity can be detected in clinical diagnostic specimens from patients with cytologically confirmed lung cancer. Should telomerase prove to be a valuable tumor marker, positivity in diagnostic specimens may obvitate the need for more invasive procedures. Future studies using diagnostic specimens may aid in assessing the value of telomerase activity as a tumor marker.",
author = "Ravi Ramakrishna and Aldous, {W. K.} and Murray, {S. P.} and Tracy, {D. P.} and Caras, {W. E.} and Dillard, {T. A.}",
year = "1998",
month = "10",
day = "1",
language = "English (US)",
volume = "114",
pages = "305S",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Telomerase activity in cytologically positive bronchoscopy, thoracentesis and fine needle specimens

AU - Ramakrishna, Ravi

AU - Aldous, W. K.

AU - Murray, S. P.

AU - Tracy, D. P.

AU - Caras, W. E.

AU - Dillard, T. A.

PY - 1998/10/1

Y1 - 1998/10/1

N2 - Purpose: The ribonucleoprotein enzyme telomerase occurs in immortal lines of mammalian cells including germ cells and most malignancies. The activity of telomerase has potential to emerge as a clinical tumor marker in prognosis or therapeutic options for lung cancer. Telomerase activity has been described in surgical and autopsy specimens of carcinomas but seldom in diagnositc specimens. We prospectively evaluated the feasibility of assessing telomerase activity in diagnostic specimens of thoracic neoplasms. Methods: We assessed telomerase activity in twenty-five bronchoscopic, thoracentesis and fine needle specimens by gel electrophoresis and a PCR ELISA assay using a single blinded study design. The clinical specimens had cytologically confirmed malignancy consisting of 9 small cell carcinomas and 16 non-small cell lung carcinomas including 2 carcinomas metastatic to the thorax. In addition, we noted an absence of significant telomerase activity by the gel electrophoresis technique in four patients with pneumonia, trapped lung or eosinophilic pleuritis. Results: We found telomerase activity by gel electrophoresis in 17 of 25 specimens (68%) including 10 of 13 broncoscopy specimens (77 %), 3 of 8 thoracentesis specimens (38 %) and 4 of 4 fine needle aspirates (100%). When we examined the results by tissue type of carcinoma we found that 6 of 9 small cell carcinomas (68%), and 11 of 16 non-small cell specimens (69%) had gel activity. Six specimens (24%) had relatively high telomerase activities (>0.312 A 450-690) by PCR ELISA assay. These consisted of 2 of 9 small cell (22%) and 4 of 16 non-small cell specimens (25%). Brushings, transbronchial needle aspirates and fine needle aspirates appeared to have greater combined sensitivity (92%) than pleural fluid and lavage specimens (42%). Conclusions: Detection of telomerase activity in thoracic malignancies appears feasible from clinical diagnostic specimens such as bronchoscopy, thoracentesis and fine needle aspirates. The prevalence of telomerase activity by gel electrophoresis was similar in the small cell and non-small cell specimens in this study. Telomerase activity has moderate sensitivity as an indicator of cytologically confirmed malignancy. Clinical Implications: Telomerase activity can be detected in clinical diagnostic specimens from patients with cytologically confirmed lung cancer. Should telomerase prove to be a valuable tumor marker, positivity in diagnostic specimens may obvitate the need for more invasive procedures. Future studies using diagnostic specimens may aid in assessing the value of telomerase activity as a tumor marker.

AB - Purpose: The ribonucleoprotein enzyme telomerase occurs in immortal lines of mammalian cells including germ cells and most malignancies. The activity of telomerase has potential to emerge as a clinical tumor marker in prognosis or therapeutic options for lung cancer. Telomerase activity has been described in surgical and autopsy specimens of carcinomas but seldom in diagnositc specimens. We prospectively evaluated the feasibility of assessing telomerase activity in diagnostic specimens of thoracic neoplasms. Methods: We assessed telomerase activity in twenty-five bronchoscopic, thoracentesis and fine needle specimens by gel electrophoresis and a PCR ELISA assay using a single blinded study design. The clinical specimens had cytologically confirmed malignancy consisting of 9 small cell carcinomas and 16 non-small cell lung carcinomas including 2 carcinomas metastatic to the thorax. In addition, we noted an absence of significant telomerase activity by the gel electrophoresis technique in four patients with pneumonia, trapped lung or eosinophilic pleuritis. Results: We found telomerase activity by gel electrophoresis in 17 of 25 specimens (68%) including 10 of 13 broncoscopy specimens (77 %), 3 of 8 thoracentesis specimens (38 %) and 4 of 4 fine needle aspirates (100%). When we examined the results by tissue type of carcinoma we found that 6 of 9 small cell carcinomas (68%), and 11 of 16 non-small cell specimens (69%) had gel activity. Six specimens (24%) had relatively high telomerase activities (>0.312 A 450-690) by PCR ELISA assay. These consisted of 2 of 9 small cell (22%) and 4 of 16 non-small cell specimens (25%). Brushings, transbronchial needle aspirates and fine needle aspirates appeared to have greater combined sensitivity (92%) than pleural fluid and lavage specimens (42%). Conclusions: Detection of telomerase activity in thoracic malignancies appears feasible from clinical diagnostic specimens such as bronchoscopy, thoracentesis and fine needle aspirates. The prevalence of telomerase activity by gel electrophoresis was similar in the small cell and non-small cell specimens in this study. Telomerase activity has moderate sensitivity as an indicator of cytologically confirmed malignancy. Clinical Implications: Telomerase activity can be detected in clinical diagnostic specimens from patients with cytologically confirmed lung cancer. Should telomerase prove to be a valuable tumor marker, positivity in diagnostic specimens may obvitate the need for more invasive procedures. Future studies using diagnostic specimens may aid in assessing the value of telomerase activity as a tumor marker.

UR - http://www.scopus.com/inward/record.url?scp=33750253288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750253288&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750253288

VL - 114

SP - 305S

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -